Keywords: fludara, cleared, first-line, use, cll, schering, ag

Fludara cleared for first-line use in CLL

Article | 17 February 2003

Print This

Schering AG of Germany has been granted marketing approval in Europe toextend the indications for its cancer drug Fludara (fludarabine) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in